- Home
- GPOR vs SLNO Comparison
GPOR vs SLNO Comparison
Compare GPOR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPOR
- SLNO
- Stock Information
- Founded
- GPOR 1997
- SLNO 1999
- Country
- GPOR United States
- SLNO United States
- Employees
- GPOR N/A
- SLNO N/A
- Industry
- GPOR Oil & Gas Production
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GPOR Energy
- SLNO Health Care
- Exchange
- GPOR Nasdaq
- SLNO Nasdaq
- Market Cap
- GPOR 3.3B
- SLNO 3.8B
- IPO Year
- GPOR N/A
- SLNO 2014
- Fundamental
- Price
- GPOR $173.88
- SLNO $67.74
- Analyst Decision
- GPOR Buy
- SLNO Strong Buy
- Analyst Count
- GPOR 8
- SLNO 10
- Target Price
- GPOR $216.14
- SLNO $112.50
- AVG Volume (30 Days)
- GPOR 251.8K
- SLNO 1.6M
- Earning Date
- GPOR 08-05-2025
- SLNO 08-06-2025
- Dividend Yield
- GPOR N/A
- SLNO N/A
- EPS Growth
- GPOR N/A
- SLNO N/A
- EPS
- GPOR N/A
- SLNO N/A
- Revenue
- GPOR $1,135,446,000.00
- SLNO $32,656,999.00
- Revenue This Year
- GPOR $61.02
- SLNO N/A
- Revenue Next Year
- GPOR $11.27
- SLNO $175.39
- P/E Ratio
- GPOR N/A
- SLNO N/A
- Revenue Growth
- GPOR 26.64
- SLNO N/A
- 52 Week Low
- GPOR $135.84
- SLNO $41.50
- 52 Week High
- GPOR $210.32
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- GPOR 53.19
- SLNO 36.13
- Support Level
- GPOR $170.27
- SLNO $66.29
- Resistance Level
- GPOR $176.54
- SLNO $70.74
- Average True Range (ATR)
- GPOR 3.88
- SLNO 3.18
- MACD
- GPOR 1.65
- SLNO -0.49
- Stochastic Oscillator
- GPOR 82.94
- SLNO 19.84
About GPOR Gulfport Energy Corporation
Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.